Agape ATP (NASDAQ: ATPC) warned by Nasdaq over $1 minimum bid price

Rhea-AI Filing Summary

Agape ATP Corporation reported that Nasdaq has notified the company it no longer meets the continued listing requirement to maintain a minimum bid price of $1 per share under Nasdaq Listing Rule 5550(a)(2). The notice is based on closing bid prices from December 10, 2025 to January 26, 2026.

The company has 180 calendar days, until July 27, 2026, to regain compliance. If it meets other Nasdaq Capital Market listing standards, it may qualify for an additional 180‑day period and could use measures such as a reverse stock split. Failing to regain compliance could lead to delisting. Agape ATP is evaluating options and intends to regain compliance, but there is no assurance it will succeed.

Positive

• None.

Negative

• Nasdaq minimum bid price deficiency and delisting risk: Nasdaq notified Agape ATP that its stock failed to meet the $1 per share minimum bid requirement, triggering a 180‑day compliance period and the possibility that its securities could ultimately be delisted if compliance is not restored.

Insights

Equity market listing & compliance analyst

Nasdaq bid-price deficiency creates real delisting risk for Agape ATP.

Agape ATP Corporation has received a Nasdaq notice that its common stock no longer meets the $1 minimum bid price requirement under Rule 5550(a)(2), based on trading from December 10, 2025 to January 26, 2026. This formally places the stock in a compliance period rather than immediate delisting.

The company now has July 27, 2026 as a deadline to restore the bid price to compliance. The filing notes the possibility of an additional 180‑day extension if other initial listing standards and market value of publicly held shares requirements are met and the company commits to a cure, potentially via a reverse stock split.

If Agape ATP cannot regain compliance or qualify for the second grace period, Nasdaq may move to delist its securities. The company states it is evaluating options and intends to regain compliance, but explicitly acknowledges there is no assurance it will satisfy Nasdaq’s continued listing requirements.

false 0001713210 0001713210 2026-01-27 2026-01-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 27, 2026

AGAPE ATP CORPORATION

(Exact name of Registrant as specified in its charter)

Nevada		001-41835		36-4838886
(State or other jurisdiction		(Commission		(IRS Employer
of incorporation)		File Number)		Identification No.)

1705 – 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia,

Taman Desa, Kuala Lumpur, Malaysia (Postal Code: 58100).

(Address of principal executive offices, including zip code)

Registrant’s phone number, including area code

+(60) 192230099

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001		ATPC		NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On January 27, 2026, Agape ATP Corporation (the “Company”) received a letter from the Listing Qualifications staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that based on the closing bid price of the Company for the period from December 10, 2025 to January 26, 2026, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share.

Nasdaq has provided the Company with an 180 calendar days compliance period, or until July 27, 2026, in which to regain compliance with Nasdaq continued listing requirement. In the event that the Company does not regain compliance in the compliance period, the Company may be eligible for an additional 180 calendar days, should the Company meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and is able to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. However, if it appears that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company’s securities will be subject to delisting.

The Company is currently evaluating options to regain compliance and intends to timely regain compliance with Nasdaq’s continued listing requirement. Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with that rule or will otherwise be in compliance with other Nasdaq continued listing requirement.

On January 29, 2026, the Company issued a press release (the “Press Release”) announcing receipt of the letter from Nasdaq. The Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Exhibit Index

Exhibit No.		Description
99.1		Press Release dated January 29, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: January 29, 2026	AGAPE ATP CORPORATION
	By:	/s/ How Kok Choong
	Name:	How Kok Choong
	Title:	Chief Executive Officer, President, Director, Secretary and Treasurer (Principal Executive Officer)

3

FAQ

What Nasdaq notice did Agape ATP (ATPC) receive about its stock listing?

Agape ATP received a Nasdaq notice that its common stock no longer meets the $1 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The determination was based on closing bid prices from December 10, 2025, through January 26, 2026.

How long does Agape ATP (ATPC) have to regain Nasdaq bid price compliance?

Agape ATP has a 180 calendar day compliance period, ending July 27, 2026, to regain compliance with Nasdaq’s $1 minimum bid price rule. During this time, it must lift its bid price sufficiently for the required period under Nasdaq standards.

Can Agape ATP (ATPC) obtain more time beyond July 27, 2026 to meet Nasdaq rules?

Agape ATP may obtain an additional 180 calendar days if it meets all other initial listing standards and the market value of publicly held shares, except the bid price, and provides written notice of its intent to cure the deficiency, potentially via a reverse stock split.

What happens if Agape ATP (ATPC) cannot regain Nasdaq compliance?

If Agape ATP cannot regain compliance or qualify for an additional grace period, Nasdaq may delist its securities. Nasdaq would provide notice that the company’s securities are subject to delisting if remedies appear insufficient or eligibility conditions are not met.

How does Agape ATP (ATPC) plan to address the Nasdaq bid price deficiency?

Agape ATP states it is evaluating options to regain compliance and intends to do so within Nasdaq’s continued listing requirements. The filing mentions that a reverse stock split could be used if necessary during a second compliance period, if granted.

Did Agape ATP (ATPC) issue a press release about the Nasdaq notice?

Yes. Agape ATP issued a press release on January 29, 2026 announcing receipt of the Nasdaq letter. This press release is identified as Exhibit 99.1 and is incorporated by reference in the current report.